Medication dosing in patients with chronic kidney disease

Area of Science:

• Nephrology
• Clinical Pharmacy
• Pharmacology

Background:

• Chronic kidney disease (CKD) affects drug pharmacokinetics and pharmacodynamics.
• Improper medication dosing in CKD patients increases the risk of adverse events.
• Evidence-based guidelines for drug dosage adjustments in CKD are essential.

Purpose of the Study:

• To provide a comprehensive review of dosage adjustments for frequently prescribed medications in CKD patients.
• To highlight critical information for managing antidiabetic, antibiotic, analgesic, and antithrombotic therapies in CKD.
• To offer guidance on patient education for over-the-counter (OTC) medications in the context of CKD.

Main Methods:

• Literature review of current clinical practice guidelines and relevant pharmacological studies.
• Analysis of drug databases and pharmacokinetic data specific to varying stages of CKD.
• Synthesis of information on common drug classes used in CKD management.

Main Results:

• Specific dosage recommendations and adjustments for antidiabetic, antibiotic, analgesic, and antithrombotic medications in CKD.
• Identification of key safety considerations and potential drug interactions.
• Essential patient teaching points for OTC medication use in CKD.

Conclusions:

• Optimizing medication dosages is paramount for ensuring patient safety in chronic kidney disease.
• Healthcare providers must be knowledgeable about drug adjustments to prevent adverse outcomes.
• Effective patient education on medication use, including OTCs, is vital for CKD management.